Concepedia

Author

Kerri Amaral

Novartis (Switzerland)

Also Known As

Kerri Amaral

2

Publications

65

Citations

2

H-Index

15

Concepts

All Affiliations

Novartis (Switzerland)
KA

About

Kerri Amaral is an author at Novartis (Switzerland) specializing in drug resistance, antibiotics, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

24

2

Medicine

1

1

24

3

Biochemistry

1

1

24

4

Immunology

1

1

24

5

Microbiology

1

1

24

Kerri Amaral

×

2

Publications

65

Citations

2

H-Index

YearCitations

Antibacterial Optimization of 4-Aminothiazolyl Analogues of the Natural Product GE2270 A: Identification of the Cycloalkylcarboxylic Acids

Matthew J. LaMarche, Jennifer A. Leeds, Kerri Amaral,

Journal of Medicinal Chemistry

2011

41

In Vivo Characterization of the Peptide Deformylase Inhibitor LBM415 in Murine Infection Models

Colin Osborne, Georg Neckermann, Evelin Fischer,

Antimicrobial Agents and Chemotherapy

2009

24

Page 1